Latuda

(Lurasidone hydrochloride)

Latuda

Drug updated on 9/15/2023

Dosage FormTablet (oral; 20 mg, 40 mg, 60 mg, 80 mg and 120 mg)
Drug ClassAtypical antipsychotic
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of schizophrenia in adults and adolescents (13 to 17 years).
  • For the treatment of depressive episode associated with bipolar I disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy.
  • For the treatment of depressive episode associated with bipolar I disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate.

Product Monograph / Prescribing Information

Document TitleYearSource
Latuda (lurasidone hydrochloride) Prescribing Information.2022Sunovion Pharmaceuticals Inc. Marlborough, MA

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines